Please assess the completion status of the following clinical trial:

Trial Title: Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants born \< 31 weeks gestational age~* Between 3 and 7 days old at time of consent~Exclusion Criteria:~* Infants with multiple congenital anomalies~* Infant with suspected/confirmed genetic anomalies~* Infant with suspected/confirmed congenital immune deficiencies

- Gender: ALL
- Minimum Age: 3 Days
- Maximum Age: 6 Months
- Healthy Volunteers: t

Study Arms:
- Intervention: NPO (Type: OTHER): Infants in this group will be made NPO approximately 4 hours prior to receiving a blood transfusion and will remain NPO until approximately 24 hours after the blood transfusion.~Pro-inflammatory cytokine response will be monitored at 3 times points.
- Control: Continue feedings (Type: OTHER): Infants in this group will be allowed to continue feedings during the transfusion at the discretion of the medical team.~Pro-inflammatory cytokine response will be monitored at 3 times points.

Based on this trial design, predict the completion outcome and termination type (if applicable).